Trial Details
COMPLETEDBasic Information
| Clinical ID | c2477 |
|---|---|
| Identifier | NCT03441581 |
| Trial Title | Eluxadoline Bile Acid Malabsorption (BAM) Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Irritable Bowel Syndrome With Diarrhea |
| Interventions | DRUG: Eluxadoline |
Participant Information
| Sponsor | Allergan |
|---|---|
| City | Rochester |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2018-02-23 |
|---|---|
| Primary Completion Date | 2020-04-28 |
| Completion Date | 2020-04-28 |